US pediatric COVID-19 cases continue to climb | CIDRAP

“Child cases have declined since a peak of 252,000 the week of September 2nd, but COVID cases among children remain extremely high. For the 15th week in a row child COVID-19 cases are above 100,000. Since the first week of September, there have been over 1.7 million additional child cases,” the AAP said.

Pediatric cases across the country have risen this fall as in-person school has resumed and the Delta (B1617.2) variant has become the dominant strain in the United States. Cases among children 17 and under are up 40% compared to the end of October.

With the looming holidays, federal experts are urging parents to vaccinate all children ages 5 and older now that pediatric COVID-19 vaccines are widely available. According to ABC News, approximately one third of US children ages 5 to 17 have received at least one COVID-19 vaccine dose.

Pfizer says vaccine 100% effective in teens

In related news, Pfizer and BioNTech announced yesterday that topline results from a longer-term analysis showed that their vaccine was 100% effective against COVID-19 in children ages 12 through 15 up to 4 months after the second dose.

“These are the first and only disclosed longer-term data demonstrating the safety and efficacy of a COVID-19 vaccine in individuals 12 through 15 years of age,” said Ugur Sahin, CEO and co-founder of BioNTech, in a press release.

Source: US pediatric COVID-19 cases continue to climb | CIDRAP